【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 16
2 Introduction 17
2.1 Bone Grafts and Substitutes Overview 17
3 Products under Development 18
3.1 Bone Grafts and Substitutes – Pipeline Products by Stage of Development 18
3.2 Bone Grafts and Substitutes – Pipeline Products by Segment 19
3.3 Bone Grafts and Substitutes – Pipeline Products by Territory 20
3.4 Bone Grafts and Substitutes – Pipeline Products by Regulatory Path 21
3.5 Bone Grafts and Substitutes – Pipeline Products by Estimated Approval Date 22
3.6 Bone Grafts and Substitutes – Ongoing Clinical Trials 23
4 Bone Grafts and Substitutes – Pipeline Products under Development by Companies 24
4.1 Bone Grafts and Substitutes Companies – Pipeline Products by Stage of Development 24
4.2 Bone Grafts and Substitutes – Pipeline Products by Stage of Development 28
5 Bone Grafts and Substitutes Companies and Product Overview 32
5.1 aap Implantate AG Company Overview 32
5.1.1 aap Implantate AG Pipeline Products & Ongoing Clinical Trials Overview 32
5.2 Accelerated Orthopedic Technologies, Inc. Company Overview 35
5.2.1 Accelerated Orthopedic Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 35
5.3 Adaptaide Inc. Company Overview 36
5.3.1 Adaptaide Inc. Pipeline Products & Ongoing Clinical Trials Overview 36
5.4 Adocia Company Overview 37
5.4.1 Adocia Pipeline Products & Ongoing Clinical Trials Overview 37
5.5 Advanced Biologics, LLC Company Overview 41
5.5.1 Advanced Biologics, LLC Pipeline Products & Ongoing Clinical Trials Overview 41
5.6 Agenta Biotechnologies, Inc. Company Overview 42
5.6.1 Agenta Biotechnologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 42
5.7 Allergan, Inc. Company Overview 43
5.7.1 Allergan, Inc. Pipeline Products & Ongoing Clinical Trials Overview 43
5.8 Alphatec Holdings, Inc. Company Overview 46
5.8.1 Alphatec Holdings, Inc. Pipeline Products & Ongoing Clinical Trials Overview 46
5.9 Amedica Corporation Company Overview 48
5.9.1 Amedica Corporation Pipeline Products & Ongoing Clinical Trials Overview 48
5.10 Anika Therapeutics, Inc. Company Overview 50
5.10.1 Anika Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 50
5.11 ApaTech Limited (Inactive) Company Overview 53
5.11.1 ApaTech Limited (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 53
5.12 Aperion Biologics Corporation Company Overview 55
5.12.1 Aperion Biologics Corporation Pipeline Products & Ongoing Clinical Trials Overview 55
5.13 Arthro Kinetics AG Company Overview 62
5.13.1 Arthro Kinetics AG Pipeline Products & Ongoing Clinical Trials Overview 62
5.14 Aursos, Inc Company Overview 63
5.14.1 Aursos, Inc Pipeline Products & Ongoing Clinical Trials Overview 63
5.15 Berkeley Advanced Biomaterials, Inc. Company Overview 64
5.15.1 Berkeley Advanced Biomaterials, Inc. Pipeline Products & Ongoing Clinical Trials Overview 64
5.16 Bio2 Technologies, Inc. Company Overview 67
5.16.1 Bio2 Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 67
5.17 Bioactive Bone Substitutes Ltd. Company Overview 68
5.17.1 Bioactive Bone Substitutes Ltd. Pipeline Products & Ongoing Clinical Trials Overview 68
5.18 Bioregeneration Technologies, Inc Company Overview 69
5.18.1 Bioregeneration Technologies, Inc Pipeline Products & Ongoing Clinical Trials Overview 69
5.19 Bio-Scaffold International Pte Ltd Company Overview 70
5.19.1 Bio-Scaffold International Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 70
5.20 BioSET, Inc Company Overview 74
5.20.1 BioSET, Inc Pipeline Products & Ongoing Clinical Trials Overview 74
5.21 Bioventus LLC Company Overview 81
5.21.1 Bioventus LLC Pipeline Products & Ongoing Clinical Trials Overview 81
5.22 Body Organ Biomedical Corp. Company Overview 83
5.22.1 Body Organ Biomedical Corp. Pipeline Products & Ongoing Clinical Trials Overview 83
5.23 Bone Solutions, Inc. Company Overview 85
5.23.1 Bone Solutions, Inc. Pipeline Products & Ongoing Clinical Trials Overview 85
5.24 BoneGrafix, Inc. Company Overview 90
5.24.1 BoneGrafix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 90
5.25 BoneSupport AB Company Overview 91
5.25.1 BoneSupport AB Pipeline Products & Ongoing Clinical Trials Overview 91
5.26 Calcitec, Inc. Company Overview 95
5.26.1 Calcitec, Inc. Pipeline Products & Ongoing Clinical Trials Overview 95
5.27 Cellright Technologies, LLC Company Overview 96
5.27.1 Cellright Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 96
5.28 CeraPedics, Inc. Company Overview 97
5.28.1 CeraPedics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 97
5.29 Chinese University of Hong Kong Company Overview 104
5.29.1 Chinese University of Hong Kong Pipeline Products & Ongoing Clinical Trials Overview 104
5.30 Citrics Biomedical, LLC Company Overview 105
5.30.1 Citrics Biomedical, LLC Pipeline Products & Ongoing Clinical Trials Overview 105
5.31 CollPlant Ltd. Company Overview 106
5.31.1 CollPlant Ltd. Pipeline Products & Ongoing Clinical Trials Overview 106
5.32 ConMed Corporation Company Overview 108
5.32.1 ConMed Corporation Pipeline Products & Ongoing Clinical Trials Overview 108
5.33 CoreBone Ltd. Company Overview 110
5.33.1 CoreBone Ltd. Pipeline Products & Ongoing Clinical Trials Overview 110
5.34 ElutInc Company Overview 111
5.34.1 ElutInc Pipeline Products & Ongoing Clinical Trials Overview 111
5.35 EpiBone Company Overview 112
5.35.1 EpiBone Pipeline Products & Ongoing Clinical Trials Overview 112
5.36 Exactech, Inc. Company Overview 113
5.36.1 Exactech, Inc. Pipeline Products & Ongoing Clinical Trials Overview 113
5.37 Graftoss Limited Company Overview 115
5.37.1 Graftoss Limited Pipeline Products & Ongoing Clinical Trials Overview 115
5.38 Graftys SAS Company Overview 116
5.38.1 Graftys SAS Pipeline Products & Ongoing Clinical Trials Overview 116
5.39 Inion Oy Company Overview 122
5.39.1 Inion Oy Pipeline Products & Ongoing Clinical Trials Overview 122
5.40 Innovia LLC Company Overview 123
5.40.1 Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 123
5.41 Innovoss Inc. Company Overview 124
5.41.1 Innovoss Inc. Pipeline Products & Ongoing Clinical Trials Overview 124
5.42 Integra LifeSciences Holdings Corporation Company Overview 125
5.42.1 Integra LifeSciences Holdings Corporation Pipeline Products & Ongoing Clinical Trials Overview 125
5.43 ISTO Technologies, Inc. Company Overview 127
5.43.1 ISTO Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 127
5.44 Jellagen Pty Ltd Company Overview 128
5.44.1 Jellagen Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 128
5.45 kasios sas Company Overview 129
5.45.1 kasios sas Pipeline Products & Ongoing Clinical Trials Overview 129
5.46 Kensey Nash Corporation (Inactive) Company Overview 130
5.46.1 Kensey Nash Corporation (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 130
5.47 Kytogenics Pharmaceuticals, Inc. Company Overview 131
5.47.1 Kytogenics Pharmaceuticals, Inc. Pipeline Products & Ongoing Clinical Trials Overview 131
5.48 Lacerta Technologies GmbH Company Overview 132
5.48.1 Lacerta Technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview 132
5.49 Mariel Therapeutics, Inc. Company Overview 134
5.49.1 Mariel Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 134
5.50 Maxigen Biotech Inc. Company Overview 135
5.50.1 Maxigen Biotech Inc. Pipeline Products & Ongoing Clinical Trials Overview 135
5.51 Medtronic plc Company Overview 138
5.51.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 138
5.52 Meta Biomed Co., Ltd. Company Overview 142
5.52.1 Meta Biomed Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 142
5.53 Miromatrix Medical Inc. Company Overview 144
5.53.1 Miromatrix Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 144
5.54 N2 Biomedical Company Overview 145
5.54.1 N2 Biomedical Pipeline Products & Ongoing Clinical Trials Overview 145
5.55 National Center of Innovation for Biomaterials in Orthopaedic Research Company Overview 146
5.55.1 National Center of Innovation for Biomaterials in Orthopaedic Research Pipeline Products & Ongoing Clinical Trials Overview 146
5.56 Noraker Company Overview 147
5.56.1 Noraker Pipeline Products & Ongoing Clinical Trials Overview 147
5.57 NovaBone Products, LLC. Company Overview 149
5.57.1 NovaBone Products, LLC. Pipeline Products & Ongoing Clinical Trials Overview 149
5.58 Nutech Medical, Inc Company Overview 150
5.58.1 Nutech Medical, Inc Pipeline Products & Ongoing Clinical Trials Overview 150
5.59 NuVasive, Inc. Company Overview 151
5.59.1 NuVasive, Inc. Pipeline Products & Ongoing Clinical Trials Overview 151
5.60 Orthogen LLC Company Overview 155
5.60.1 Orthogen LLC Pipeline Products & Ongoing Clinical Trials Overview 155
5.61 OssiFi, Inc. Company Overview 156
5.61.1 OssiFi, Inc. Pipeline Products & Ongoing Clinical Trials Overview 156
5.62 OsteoNovus, LLC Company Overview 157
5.62.1 OsteoNovus, LLC Pipeline Products & Ongoing Clinical Trials Overview 157
5.63 PolyPid, Ltd. Company Overview 158
5.63.1 PolyPid, Ltd. Pipeline Products & Ongoing Clinical Trials Overview 158
5.64 Promimic AB Company Overview 160
5.64.1 Promimic AB Pipeline Products & Ongoing Clinical Trials Overview 160
5.65 ReCaPP Company Overview 161
5.65.1 ReCaPP Pipeline Products & Ongoing Clinical Trials Overview 161
5.66 RepRegen Ltd. (Inactive) Company Overview 162
5.66.1 RepRegen Ltd. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 162
5.67 Revivicor, Inc. Company Overview 164
5.67.1 Revivicor, Inc. Pipeline Products & Ongoing Clinical Trials Overview 164
5.68 RTI Surgical, Inc. Company Overview 166
5.68.1 RTI Surgical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 166
5.69 Sanofi Company Overview 168
5.69.1 Sanofi Pipeline Products & Ongoing Clinical Trials Overview 168
5.70 SIRAKOSS Limited Company Overview 170
5.70.1 SIRAKOSS Limited Pipeline Products & Ongoing Clinical Trials Overview 170
5.71 Soft Tissue Regeneration, Inc. Company Overview 171
5.71.1 Soft Tissue Regeneration, Inc. Pipeline Products & Ongoing Clinical Trials Overview 171
5.72 Soteira Inc. Company Overview 175
5.72.1 Soteira Inc. Pipeline Products & Ongoing Clinical Trials Overview 175
5.73 Spineway Company Overview 176
5.73.1 Spineway Pipeline Products & Ongoing Clinical Trials Overview 176
5.74 SurgaColl Technologies Ltd Company Overview 178
5.74.1 SurgaColl Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 178
5.75 TBF Genie Tissulaire Company Overview 181
5.75.1 TBF Genie Tissulaire Pipeline Products & Ongoing Clinical Trials Overview 181
5.76 The Johns Hopkins University Company Overview 183
5.76.1 The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 183
5.77 Tissue Regeneration Systems, Inc. Company Overview 184
5.77.1 Tissue Regeneration Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 184
5.78 Trinity College Dublin Company Overview 185
5.78.1 Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview 185
5.79 University of California, San Diego Company Overview 186
5.79.1 University of California, San Diego Pipeline Products & Ongoing Clinical Trials Overview 186
5.80 University of Edinburgh Company Overview 187
5.80.1 University of Edinburgh Pipeline Products & Ongoing Clinical Trials Overview 187
5.81 University of Memphis Company Overview 189
5.81.1 University of Memphis Pipeline Products & Ongoing Clinical Trials Overview 189
5.82 University of Nottingham’s School Of Pharmacy Company Overview 190
5.82.1 University of Nottingham’s School Of Pharmacy Pipeline Products & Ongoing Clinical Trials Overview 190
5.83 University of Pecs Company Overview 191
5.83.1 University of Pecs Pipeline Products & Ongoing Clinical Trials Overview 191
5.84 University of South Florida Company Overview 192
5.84.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 192
5.85 Wayne State University Company Overview 193
5.85.1 Wayne State University Pipeline Products & Ongoing Clinical Trials Overview 193
5.86 Wound Management Technologies, Inc. Company Overview 194
5.86.1 Wound Management Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 194
5.87 Wright Medical Group, Inc. Company Overview 196
5.87.1 Wright Medical Group, Inc. Pipeline Products & Ongoing Clinical Trials Overview 196
5.88 X-spine Systems, Inc. Company Overview 203
5.88.1 X-spine Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 203
5.89 Xtant Medical Holdings, Inc. Company Overview 204
5.89.1 Xtant Medical Holdings, Inc. Pipeline Products & Ongoing Clinical Trials Overview 204
6 Bone Grafts and Substitutes- Recent Developments 207
7 Appendix 267
7.1 Methodology 267
7.2 About GlobalData 269
7.3 Contact Us 270
7.4 Disclaimer 270
【レポート販売概要】
■ タイトル：世界における骨移植片/骨代用材の製品パイプライン動向2015■ 英文：Bone Grafts and Substitutes - Pipeline Review, 2015
■ 発行日：2015年10月1日
■ 調査会社：GlobalData
■ 商品コード：GDME0079EPD
■ 調査対象地域：グローバル
- Cryptococcosis：グローバル臨床試験レビューH1, 2013Cryptococcosis Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Cryptococcosis Global Clinical Trials Review, H1, 2013" provides data on the Cryptococcosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cryptococcosis. It includes an overview of the trial numbers and their recruitment status as per …
- 電気生理学的検査用カテーテル（医療機器）のグローバル新興国市場（2012-2018）BRICSS Diagnostic Electrophysiology Catheters market value is expected to reach US$710 million by 2016, primarily supported by the product types - Conventional EP Diagnostic Catheters, Advanced EP and Diagnostic Catheters and Ultrasound EP Diagnostic Catheters. China accounts for nearly 25% of the market share and India claims more than 25%. In terms of CAGR, China is the fastest growing region wh …
- 世界のギヤレス風力タービン市場動向（2012-2016）TechNavio's analysts forecast the Global Gearless Wind Turbine market to grow at a CAGR of 14.43 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increased potential in offshore wind turbines. The Global Gearless Wind Turbine market has also been witnessing an increase in environmental awareness. However, the negative effect of wind turbines on wi …
- B型慢性肝炎の疫学的予測（～2024）EpiCast Report: Chronic Hepatitis B - Epidemiology Forecast to 2024 Summary The Hepatitis B Virus (HBV) can cause both acute and chronic liver disease. HBV is typically transmitted through contact with infectious blood or bodily fluid, including vertical transmission from mother to child at birth and transmission via sexual intercourse. Risk factors of chronic hepatitis B (CHB) include unprotected …
- フローリングの世界市場分析：製品別（ソフトカバー、弾力性フローリング、非弾力性フローリング、継ぎ目のないフローリング）、用途別（住宅、商業、工業用）、セグメント予測、-2020The global resilient flooring market size is projected to reach USD 92.47 Billion by 2022, growing at a CAGR of over 10.0% from 2015 to 2022, according to a new report by Grand View Research, Inc. The growth prospects for the resilient flooring market are bullish on account of increased substitution of laminate floors by vinyl tiles. High demand for luxury vinyl tiles (LVT) and vinyl composite til …
- Inpex Corporation社の石油・ガス開発・生産動向及びコスト分析（2013年）Inpex Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - 2013 Summary Inpex Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key ope …
- 両心室ペーシング（心臓同期療法/CRT）医療機器のグローバル市場（2012-2018）Global Cardiac Resynchronization Therapy (CRT) sector is projected to reach US$3.1 billion by 2016. The North America accounts for nearly 39% (2015) of the global value while Europe claims approximately 32% (2018). Asia-Pacific is the fastest growing region with a CAGR of 12.8% driving a market value of US$590 million by 2016. On a global scale, projections for Cardiac Resynchronization Therapy De …
- ヘアドライヤーの世界市場2017-2021About Hair DryerHair dryers are considered as personal care appliances that are used for drying hair. Some hair dryers are also used for different hair styling. Within the personal care appliances space, other than hair dryers, hair straighteners and hair stylers have been considered in the other segment. Technavio’s analysts forecast the global hair dryer market to grow at a CAGR of 4.60% during …
- 油田用プロセス化学薬品のグローバル市場動向（2014-2018）About Oilfield Process Chemicals Oilfield process chemicals are products that are used during the exploration and processing stages of oil and gas in the resource area or field. The Oil and Gas industry is the end-user of such chemicals. Some of the key functions of oilfield process chemicals include control of corrosion, fluid loss, bacteria, wax and asphaltene, hydrogen sulfide, and foam. The ma …
- ファンタジー・スポーツの世界市場2015-2019About Fantasy Sports A fantasy sport, also known as rotisserie or owner simulation or roto, is an online game that allows end-users to own a fantasy sport team along with real-life professional players. The performance of the fantasy sport team depends on the real-life performance of players. End-users participate in various fantasy sports events after paying league fees. The winners of these spor …
- Bonterra Energy Corp：石油・ガスの開発・生産動向及びコスト分析– Q1, 2013Bonterra Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q1, 2013 Summary Bonterra Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source f …
- プロピレンの世界市場動向及び予測2015The present report is an essential resource for a one looking for detailed information on the world propylene market. The report covers data on global, regional and national markets including present and future trends for supply and demand, prices, and downstream industries. In addition to the analytical part, the report provides a range of tables and figures which all together give a true insight …
- 医療機器業界のM&A及び投資動向（月別）：July 2013Medical Equipment Monthly Deals Analysis: July 2013- M&A and Investment Trends Summary GlobalData's “Medical Equipment Monthly Deals Analysis: July 2013- M&A and Investment Trends” report is an essential source of data and trend analysis on the mergers and acquisitions (M&As) and financings in the medical equipment industry. The report provides detailed information on M&As, equity/debt offerings, …
- 漂白剤の世界市場予測（～2023年）：アゾジカルボンアミド、過酸化水素、アスコルビン酸、過酸化アセトン、二酸化塩素The bleaching agents market is estimated at USD 728.6 Million in 2018 and is projected to reach USD 953.8 Million by 2023, growing at a CAGR of 5.5% during the forecast period. The market size of bleaching agents includes both, the valuation of existing bleaching agents and incremental revenue year-on-year. The global demand for bleaching agents is increasing significantly due to the rising demand …
- 慢性気管支炎(Chronic Bronchitis)：世界の治験レビュー2014年下半期版Chronic Bronchitis Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Chronic Bronchitis Global Clinical Trials Review, H2, 2014" provides data on the Chronic Bronchitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chronic Bronchitis. It includes an overview of the trial numbers and their recruitme …
